Find More Contacts for Concert Pharmaceuticals
Protected Content
CEO
Non-Management, Executive Management
4 emails found 5 phone numbers found
View contacts for Concert Pharmaceuticals to access new leads and connect with decision-makers.
View All Contacts
  • Contact Email info@concertpharma.com
  • Phone Number 7816745322

Concert Pharmaceuticals is a clinical-stage biotechnology company dedicated to creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium.

Concert applies its innovative precision deuterium chemistry platform to modify specific properties of validated drug molecules, yielding a rich pipeline of

new chemical entities (NCEs). Concert leverages decades of pharmaceutical experience to create novel drug candidates with the potential for efficacy and safety, while greatly reducing R&D risk, time, and expense.

Lists Featuring This Company

Tuck School of Business at Dartmouth College Alumni Founded Companies
414 Number of Organizations â€¢ $7.7B Total Funding Amount â€¢ 865 Number of Investors
Biotechnology Acquired Companies With Fewer Than 100 Employees
1,857 Number of Organizations â€¢ $43.4B Total Funding Amount â€¢ 4,401 Number of Investors
Massachusetts Acquired Companies With Less Than $500M in Revenue
1,294 Number of Organizations â€¢ $37.4B Total Funding Amount â€¢ 3,492 Number of Investors
Medical Companies With Fewer Than 1000 Employees (Top 10K)
9,763 Number of Organizations â€¢ $356.9B Total Funding Amount â€¢ 32,817 Number of Investors
Concert Pharmaceuticals was acquired by Sun Pharmaceutical Industries for $576M on Jan 19, 2023. This deal was done in Cash.
Number of Sub-Orgs 1
Which industries do these Sub-Organization operate in?

Frequently Asked Questions

Where is Concert Pharmaceuticals's headquarters? Concert Pharmaceuticals is located in Lexington, Massachusetts, United States.Who invested in Concert Pharmaceuticals? Concert Pharmaceuticals has 16 investors including Biotechnology Value Fund and RA Capital Management.How much funding has Concert Pharmaceuticals raised to date? Concert Pharmaceuticals has raised .When was the last funding round for Concert Pharmaceuticals? Concert Pharmaceuticals closed its last funding round on Jun 1, 2022 from a Post-IPO Equity round.Who are Concert Pharmaceuticals's competitors? Alternatives and possible competitors to Concert Pharmaceuticals may include NovavaxAura Biosciences, and Eureka Therapeutics.